Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.prnewswire.com/news-releases/abm-therapeutics-abm-1310-granted-fast-track-designation-by-the-fda-following-orphan-drug-designation-301937168.html
https://www.prnewswire.com/news-releases/abm-therapeutics-announces-first-patient-dosed-in-phase-i-study-of-abm-1310-in-patients-with-braf-v600-in-relapsed-and-drug-resistant-primary-malignant-brain-tumors-301914312.html
https://www.clinicaltrialsarena.com/news/abm-first-patient-solid-tumours/
https://www.prnewswire.com/news-releases/abm-announces-first-patient-dosed-in-phase-i-clinical-trial-of-mek-inhibitor-for-solid-tumor-301813371.html
https://www.prnewswire.com/news-releases/abm-therapeutics-receives-ind-approval-in-china-for-braf-inhibitor-abm-1310-301433495.html